Characteristics | NLR | PLR |
---|---|---|
AUC ROCa (95% CI) | 65.2% (45.3–85.2%) | 76.2% (59.5–92.9%) |
Likelihood ratio testb | ||
ROC-cut-off valuec | - | 145.2 |
Sensitivity (95% CI) | - | 68.7% (43.7–87.5%) |
Specificity (95% CI) | - | 75.0% (56.1–93.7%) |
Characteristics | N (%) | Characteristics | N (%) |
---|---|---|---|
Mean (SD) | 61.9 (10.0) | Mean (SD) | 2.7 (1.7) |
Median (Range) | 63.0 (40.0–81.0) | Median (Range) | 2.1 (0.8–7.0) |
Female | 36 (76.6%) | Mean (SD) | 159.4 (92.1) |
Male | 11 (23.4%) | Median (Range) | 132.9 (51.7–401.2) |
ECOG 0 | 13 (27.7%) | 2D | 23 (48.9%) |
ECOG 1 | 33 (70.2%) | 3D | 24 (51.1%) |
ECOG 2 | 1 (2.1%) | ||
Mean (SD) | 36.1 (1.6) | ||
T2 | 18 (38.3%) | Median (Range) | 36 (30–45) |
T3 | 24 (51.1%) | ||
T4 | 5 (10.6%) | Mean (SD) | 22.8 (2.5) |
Median (Range) | 23.4 (9–26) | ||
N0 | 17 (36.2%) | ||
N1 | 30 (63.8%) | Mean (SD) | 58.9 (1.6) |
Median (Range) | 59.4 (52–59.4) | ||
IIA | 10 (21.3%) | ||
IIB | 7 (14.9%) | Mean (SD) | 74.7 (14.2) |
IIIA | 8 (17.0%) | Median (Range) | 77 (51–134) |
IIIC | 22 (46.8%) | ||
Without or gr. I/II | 26 (55.3%) | ||
well | 24 (51.1%) | Grade III/IV | 21 (44.7%) |
moderate | 13 (27.7%) | ||
poor | 4 (8.5%) | Without or gr. I/II | 32 (68.1%) |
without data | 6 (12.8%) | Grade III/IV | 15 (31.9%) |
Mean (SD) | 5.2 (2.0) | CR | 30 (63.8%) |
Median (Range) | 5.4 (2.1–10.0) | PR | 15 (31.9%) |
SD | 1 (2.1%) | ||
Mean (SD) | 116.3 (20.3) | PD | 1 (2.1%) |
Median (Range) | 124 (66–154) | ||
Mean (SD) | 53.0 (30.9) | ||
No | 42 (89.4%) | Median (Range) | 44 (11–136) |
Yes | 5 (10.6%) | 47 (100%) |
Characteristic | The response to treatment after 6 months |
||
---|---|---|---|
CR | non-CR | rank Wilcoxon sum test | |
Mean (SD) | 60 (10.7) | 65.1 (7.8) | ns |
Median (Range) | 59.5 (40.0–80.0) | 65.0 (52.0–81.0) | |
Male | 6 (20%) | 5 (29.4%) | ns* |
Female | 24 (80%) | 12 (70.6%) | |
T2 | 13 (43.3%) | 5 (29.4%) | |
T3 | 14 (46.7%) | 10 (58.2%) | ns# |
T4 | 3 (10.0%) | 2 (11.8%) | |
N0 | 15 (50.0%) | 2 (11.8%) | |
N1 | 15 (50.0%) | 15 (88.2%) | |
Mean (SD) | 4.7 (1.8) | 6.0 (2.1) | |
Median (Range) | 4.9 (2.1–8.0) | 5.8 (2.3–10.0) | |
Mean (SD) | 124.2 (16.9) | 103.0 (18.8) | |
Median (Range) | 127.0 (66.0–154.0) | 101.0 (68.0–132.0) | |
No | 28 (93.3%) | 14 (82.3%) | |
Yes | 2 (6.7%) | 3 (17.6%) | ns# |
N (%) | 16/30 (50%) | 16/17 (50%) | |
Mean (SD) | 2.4 (1.8) | 3.1 (1.6) | ns |
Median (Range) | 1.9 (0.8–7.0) | 3.2 (0.9–5.6) | |
N (%) | 16/30 (50%) | 16/17 (50%) | |
Mean (SD) | 118.3 (54.9) | 200.5 (104.4) | |
Median (Range) | 108.3 (51.7–256.6) | 158.9 (79.5–401.2) | |
Median (95% CI) | NR | NR | |
Median (95% CI) | NR | 26 (> 17) | |
Median (95% CI) | NR | 71 (> 33) | |
Median (95% CI) | NR | NR | |
Median (95% CI) | NR | 11 (> 10) | |
Characteristic | The response to treatment after 6 months |
||
---|---|---|---|
CR | non-CR | Fisher Exact Test | |
< 3.0 | 13 (81.2%) | 7 (43.8%) | |
≥ 3.0 | 3 (18.8%) | 9 (56.2%) | p = 0.06 |
< 160.0 | 13 (81.2%) | 9 (56.2%) | |
≥ 160.0 | 3 (18.8%) | 7 (43.8%) | p = 0.25 |
< 145.2 | 12 (75%) | 5 (31.3%) | |
≥ 145.2 | 4 (25%) | 11(68.7%) | p = 0.03 |
Characteristic | Logistic regression |
|||
---|---|---|---|---|
Univariate |
Multivariate |
|||
OR (95%CI) | Wild test | OR (95%CI) | Likelihood Ratio test | |
> 63 y |
1.7 (0.4–6.6) | p = 0.213 | - | p = 0.884 |
Male |
2.1 (0.6–7.2) | p = 0.468 | - | p = 0.082 |
T3 |
1.9 (0.5–6.9) 1.7 (0.2–13.7) | p = 0.634 | - | p = 0.940 |
N1 |
7.5 (1.4–38.7) | p = 0.006 | - | p = 0.133 |
> 4 cm |
6.6 (1.3–33.8) | p = 0.011 | - | p = 0.602 |
< 120 g/L |
8.9 (2.2–35.6) | p = 0.001 | 13.4 (2.4–74.3) | p |
2D |
1.3 (0.4–4.2) | p = 0.679 | - | p = 0.784 |
> 10 days |
6.0 (1.6–22.3) | p = 0.005 | 9.6 (1.7–52.5) | p |
No |
2.0 (0.4–9.3) | p = 0.379 | - | p = 0.555 |